The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Non-pharmacological Interventions for Gait and Balance, 2019Protective Step Training in People with Parkinson's Disease and Postural Disturbances
Study Rationale:
Falls are a common and challenging symptom of Parkinson's disease. The ability to execute a quick and effective movement after a loss of balance (e.g., a "protective step") may reduce... -
Non-pharmacological Interventions for Gait and Balance, 2019Optimizing Vibration Therapy to Improve Gait and Balance in Parkinson's Disease
Study Rationale:
Many people who have Parkinson's disease experience freezing of gait, which is an inability to walk despite intention to walk. Unfortunately, drugs rarely help with this problem... -
Non-pharmacological Interventions for Gait and Balance, 2019Project Holocue: Smart Wearable Assistive Cueing Device for Reducing Freezing of Gait
Study Rationale:
Cues, such as stripes on the ground, may help alleviate and sometimes even prevent freezing of gait in people with Parkinson's disease. However, different people prefer different... -
Non-pharmacological Interventions for Gait and Balance, 2019Vibrating Socks: A Novel Cueing Intervention to Reduce Freezing of Gait in Parkinson's Disease
Study Rationale:
Freezing of gait is a common and disabling symptom in Parkinson's disease. With freezing of gait, patients have the feeling that their feet are suddenly glued to the floor when they... -
Biomarkers of Protein Handling/Autophagy, Exosomes and Lipid, 2019Studying Blood Proteins to Improve Diagnosis and Tracking of Parkinson's Disease
Study Rationale:
Mutations (changes) in protein LRRK2 is the main genetic cause of Parkinson's disease (PD). In the past, we found that LRRK2 interacts with ribosomes, cellular protein factories. We... -
GBA Biology and Therapies, 2019Resolving the Pathophysiology of Parkinson's Disease with GBA Mutations
Study Rationale:
Mutations in the GBA gene are the greatest genetic risk factor for developing Parkinson’s disease (PD). We will systematically examine pathophysiological pathways in PD patients with...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.